Themis Bioscience GmbH (THISR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vaccine candidates using its proprietary Themaxyn vaccine platform with a vaccine vector system, loaded with antigens from a variety of non - infectious and infectious targets. Themis Bioscience develops innovative vaccine candidates for infectious diseases such as dengue, chikungunya and yellow fever virus. The company markets its products in Austria and abroad. Themis Bioscience is headquartered in Vienna, Austria.

Themis Bioscience GmbH (THISR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Themis Bioscience GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Themis Bioscience Raises USD12 Million in Series C Venture Financing 10
Themis Bioscience Secures USD10.58 Million in Series B Funding Round 11
Themis Bioscience Raises USD7.8 Million in Series B Financing 12
Partnerships 13
Themis Bioscience Enters into Partnership with CEPI 13
Licensing Agreements 14
Themis Bioscience Enters into Licensing Agreement with Max Planck Innovation 14
Equity Offering 15
Themis Bioscience Postpones IPO 15
Themis Bioscience GmbH - Key Competitors 16
Themis Bioscience GmbH - Key Employees 17
Themis Bioscience GmbH - Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Feb 26, 2018: Themis Establishes Scientific Advisory Board of Experts in Virology and Vaccine Development 19
Product News 21
06/05/2017: NIAID-Sponsored Trial of Experimental Chikungunya Vaccine Begins 21
Clinical Trials 22
Apr 11, 2017: Zika Virus: Themis Bioscience Initiates Worldwide First Study With Live Attenuated Recombinant Vaccine 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables


Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Themis Bioscience GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Themis Bioscience GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Themis Bioscience Raises USD12 Million in Series C Venture Financing 10
Themis Bioscience Secures USD10.58 Million in Series B Funding Round 11
Themis Bioscience Raises USD7.8 Million in Series B Financing 12
Themis Bioscience Enters into Partnership with CEPI 13
Themis Bioscience Enters into Licensing Agreement with Max Planck Innovation 14
Themis Bioscience Postpones IPO 15
Themis Bioscience GmbH, Key Competitors 16
Themis Bioscience GmbH, Key Employees 17

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Themis Bioscience GmbH (THISR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage

USD 250 View Report

Gujarat Themis Biosyn Ltd Strategic Analysis Review- Gujarat Themis Biosyn Ltd SWOT, Outlook, Operations and Financial Profile

Gujarat Themis Biosyn Ltd Company Profile provides strategic analysis of Gujarat Themis Biosyn Ltd Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research

USD 200 View Report

Cytocentrics Bioscience GmbH Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Cytocentrics Bioscience GmbH Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200 View Report

Themis Bioscience GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available